146 related articles for article (PubMed ID: 16778212)
1. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases.
Yeo EJ; Ryu JH; Chun YS; Cho YS; Jang IJ; Cho H; Kim J; Kim MS; Park JW
Cancer Res; 2006 Jun; 66(12):6345-52. PubMed ID: 16778212
[TBL] [Abstract][Full Text] [Related]
2. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
3. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).
Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST
Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599
[TBL] [Abstract][Full Text] [Related]
4. YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells.
Wang SW; Pan SL; Guh JH; Chen HL; Huang DM; Chang YL; Kuo SC; Lee FY; Teng CM
J Pharmacol Exp Ther; 2005 Mar; 312(3):917-25. PubMed ID: 15525795
[TBL] [Abstract][Full Text] [Related]
5. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
6. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines.
Box AH; Demetrick DJ
Carcinogenesis; 2004 Dec; 25(12):2325-35. PubMed ID: 15347600
[TBL] [Abstract][Full Text] [Related]
8. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.
Yeo EJ; Chun YS; Cho YS; Kim J; Lee JC; Kim MS; Park JW
J Natl Cancer Inst; 2003 Apr; 95(7):516-25. PubMed ID: 12671019
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.
Shin DH; Kim JH; Jung YJ; Kim KE; Jeong JM; Chun YS; Park JW
Cancer Lett; 2007 Sep; 255(1):107-16. PubMed ID: 17502124
[TBL] [Abstract][Full Text] [Related]
10. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
DeNiro M; Alsmadi O; Al-Mohanna F
Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic suppression of the cell cycle gene CDC25A in tumor cells.
Hammer S; To KK; Yoo YG; Koshiji M; Huang LE
Cell Cycle; 2007 Aug; 6(15):1919-26. PubMed ID: 17671423
[TBL] [Abstract][Full Text] [Related]
12. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
Fallone F; Britton S; Nieto L; Salles B; Muller C
Oncogene; 2013 Sep; 32(37):4387-96. PubMed ID: 23085754
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.
Hong B; Lui VW; Hui EP; Ng MH; Cheng SH; Sung FL; Tsang CM; Tsao SW; Chan AT
Invest New Drugs; 2011 Jun; 29(3):401-10. PubMed ID: 20013349
[TBL] [Abstract][Full Text] [Related]
14. [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines].
Wang F; Chen BA; Cheng J; Xu WL; Wang XM; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Zhang W; Xia GH; Pei XP; Wu WW; Yin L; Shan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):74-8. PubMed ID: 20137122
[TBL] [Abstract][Full Text] [Related]
15. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells.
Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R
Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428
[TBL] [Abstract][Full Text] [Related]
16. Using YC-1 to overcome the radioresistance of hypoxic cancer cells.
Moon SY; Chang HW; Roh JL; Kim GC; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY
Oral Oncol; 2009 Oct; 45(10):915-9. PubMed ID: 19457706
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of YC-1 on induction of VEGF and GPI genes in hypoxic human pancreatic cancer cells].
Du J; Zhao Q; Gu H; Teng XL; Qin H; Liu NZ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):486-9. PubMed ID: 17147109
[TBL] [Abstract][Full Text] [Related]
18. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.
Kim HL; Yeo EJ; Chun YS; Park JW
Int J Oncol; 2006 Jul; 29(1):255-60. PubMed ID: 16773207
[TBL] [Abstract][Full Text] [Related]
19. PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells.
Wang FZ; Peng-Jiao ; Yang NN; Chuang-Yuan ; Zhao YL; Liu QQ; Fei HR; Zhang JG
Toxicol Lett; 2013 Jul; 220(2):150-6. PubMed ID: 23639247
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells.
Chun YS; Yeo EJ; Choi E; Teng CM; Bae JM; Kim MS; Park JW
Biochem Pharmacol; 2001 Apr; 61(8):947-54. PubMed ID: 11286986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
